Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-25-005719
Filing Date
2025-02-10
Accepted
2025-02-10 19:00:08
Documents
1
Period of Report
2025-02-07

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4064
  Complete submission text file 0001493152-25-005719.txt   5805
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Issuer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141
Business Address
Cicala Peter (Reporting) CIK: 0002011534 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-11460 | Film No.: 25607170